Astrazeneca PLC Sponsored ADR

Apr 11 2:27pm ET AstraZeneca’s AGM: Resolutions Passed with Support by TipRanks Apr 11 7:05am ET AstraZeneca announces FDA approval for Fasenra by TipRanks Apr 11 6:14am ET AstraZeneca increases 2024 dividend by 7% to $3.10 per share by TipRanks Apr 09 9:00pm ET ZTS, EXAS, AZN: Which Biotech Stock Is the Better Buy? by TipRanks Apr 08 8:41am ET Nuvectis says NXP900 demonstrates robust activity in NSCLC by TipRanks Apr 08 6:58am ET AstraZeneca’s Enhertu Wins US Approval for Tumours by TipRanks Apr 07 6:04am ET ENHERTU approved for treatment of unresectable or metastatic HER2 positive by TipRanks Apr 05 7:03am ET AstraZeneca releases ADRIATIC Phase III trial results on IMFINZI by TipRanks Apr 05 6:57am ET AstraZeneca’s Imfinzi Shows Promise in Lung Cancer Trial by TipRanks Apr 05 5:56am ET AstraZeneca: Imfinzi significantly improved OS and PFS in LS-SCLS in trial by TipRanks Apr 04 12:06pm ET AstraZeneca call volume above normal and directionally bullish by TipRanks Apr 04 4:32am ET AstraZeneca placed on ‘Positive Catalyst Watch’ at JPMorgan by TipRanks Apr 02 1:58pm ET AstraZeneca Reports Voting Rights and Share Capital by TipRanks Apr 02 9:28am ET AstraZeneca’s Voydeya Wins FDA Approval by TipRanks Apr 02 8:28am ET AstraZeneca’s Cancer Drug Closer to FDA Approval by TipRanks Apr 02 7:04am ET AstraZeneca, Daiichi Sankyo datopotamab deruxtecan BLA accepted in the U.S. by TipRanks Apr 01 7:10am ET AstraZeneca announces FDA approval of Voydeya by TipRanks Apr 01 6:10am ET AstraZeneca shareholders urged to oppose EUR 18.7M pay plan for CEO, FT says by TipRanks Mar 28 2:49pm ET What Fusion Pharmaceuticals (NASDAQ:FUSN) Acquisition Means for Investors by TipRanks Mar 27 6:25am ET AstraZeneca, Sanofi announce Beyfortus approved in Japan by TipRanks Mar 27 6:24am ET AstraZeneca’s Truqap with Faslodex approved by Japanese MHLW by TipRanks Mar 26 5:07am ET QQQ ETF Update, 3/26/2024 by TipRanks Mar 25 7:57am ET AstraZeneca’s Ultomiris Revolutionizes NMOSD Treatment by TipRanks Mar 25 7:10am ET FDA approves AstraZeneca’s Ultomiris for rare nerve disease NMOSD by TipRanks Mar 25 6:17am ET AstraZeneca reports Ultomiris approved in U.S. for adults with NMOSD by TipRanks Mar 22 5:58am ET QQQ ETF Update, 3/22/2024 by TipRanks Mar 21 11:36am ET AstraZeneca put volume heavy and directionally bearish by TipRanks Mar 21 10:16am ET AstraZeneca reports follow up results from FLAURA2 Phase 3 trial by TipRanks Mar 21 2:51am ET Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (GPCR), AstraZeneca (AZN) and Biohaven Ltd. (BHVN) by TipRanks Mar 20 9:57am ET Wells Fargo downgraded, Best Buy upgraded: Wall Street’s top analyst calls by TipRanks Mar 20 8:21am ET Fusion Pharmaceuticals downgraded to Neutral from Buy at B. Riley by TipRanks